Endometriosis treatment protocol
First Claim
1. A method for treating endometriosis, comprising the step of administering to a female patient in need of such treatment a pharmaceutical composition in a form suitable for vaginal or rectal delivery, the pharmaceutical composition comprising a pharmaceutically effective amount of an aromatase inhibitor.
0 Assignments
0 Petitions
Accused Products
Abstract
The endometriosis treatment protocol provides for administering to a female patient in need of treatment for endometriosis a pharmaceutical composition in a form suitable for vaginal or rectal delivery having a pharmaceutically effective amount of an aromatase inhibitor, which may be either a steroid or non-steroidal. The pharmaceutical composition may be formed as a vaginal suppository, a rectal suppository, a vaginal gel, a rectal gel, a vaginal cream or a rectal cream. The pharmaceutical composition may optionally have pharmaceutically effective amounts of progesterone and calcitriol, and may be administered in combination with an oral COX-2 inhibitor. Alternatively, the pharmaceutical composition comprises an aromatase inhibitor administered vaginally or rectally and is administered in combination with oral calcitriol and the oral COX-2 inhibitor. The aromatase inhibitor is either steroidal or non-steroidal.
-
Citations
27 Claims
- 1. A method for treating endometriosis, comprising the step of administering to a female patient in need of such treatment a pharmaceutical composition in a form suitable for vaginal or rectal delivery, the pharmaceutical composition comprising a pharmaceutically effective amount of an aromatase inhibitor.
-
23. A method for treating endometriosis, comprising the step of administering to a female patient in need of such treatment a composition comprising pharmaceutically effective amounts of an aromatase inhibitor, progesterone, and calcitriol, wherein the composition is in the form of a vaginal suppository.
-
24. A method for treating endometriosis, comprising the step of administering to a female patient in need of such treatment a composition comprising pharmaceutically effective amounts of an aromatase inhibitor and progesterone, wherein the composition is in the form of a vaginal suppository.
-
25. A pharmaceutical composition for the treatment of endometriosis, comprising:
-
an effective amount of an aromatase inhibitor;
an effective amount of progesterone; and
an effective amount of calcitriol;
wherein the pharmaceutical composition is in a form selected from the group consisting of a vaginal suppository, a vaginal gel and a vaginal cream.
-
-
26. A pharmaceutical composition for the treatment of endometriosis, comprising:
-
an effective amount of an aromatase inhibitor;
an effective amount of progesterone; and
an effective amount of calcitriol;
wherein the pharmaceutical composition is in a form selected from the group consisting of a rectal suppository, a rectal gel and a rectal cream.
-
-
27. A pharmaceutical composition for the treatment of endometriosis, comprising:
-
an effective amount of an aromatase inhibitor; and
an effective amount of progesterone;
wherein the pharmaceutical composition is in a form selected from the group consisting of a rectal suppository, a rectal gel and a rectal cream.
-
Specification